Landscape Capital Management »

An2 Therapeutics shares owned by Landscape Capital Management

Quarter-by-quarter ownership of An2 Therapeutics (ANTX) shares owned by Landscape Capital Management from 13F filings

Historical chart of Landscape Capital Management investment in An2 Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including An2 Therapeutics held by Landscape Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in An2 Therapeutics by Landscape Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $492k 432k 1.14
2025-09-30 $580k 457k 1.27
2025-06-30 $525k 495k 1.06

More positions owned by Landscape Capital Management

Heico Corp Cl A (HEI.A)
Monster Beverage Corp (MNST)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Constellation Brands Cl A (STZ)
Fox Corp Cl B Com (FOX)
ConAgra Foods (CAG)
Sphere Entertainment Cl A (SPHR)
Altria (MO)
Fiserv (FI)
Celsius Hldgs Com New (CELH)
American Eagle Outfitters (AEO)
Molson Coors Beverage CL B (TAP)
Dollar General (DG)
Rollins (ROL)
Affirm Hldgs Com Cl A (AFRM)

View all positions for Landscape Capital Management

Top funds holding An2 Therapeutics

Almitas Capital
Vanguard Group
Pfizer
Stonepine Capital Management
Peapod Lane Capital
Bank of Nova Scotia
Landscape Capital Management
Renaissance Technologies
BlackRock
Two Sigma Advisers
Geode Capital Management
Two Sigma Investments
Woodline Partners
State Street Corporation
Rangeley Capital

View all funds holding An2 Therapeutics